logo
TD Cowen lowers view on this telehealth stock

TD Cowen lowers view on this telehealth stock

CNBC29-04-2025

Telehealth company Hims & Hers has limited near-term upside potential, according to TD Cowen. The firm downgraded shares to hold from buy in a Tuesday note. Analyst Jonna Kim also lowered her price target to $30 per share from $44, which indicates shares gaining just 5.3% from Monday's close. The "stock could be range-bound in a post GLP-1 shortage world," Kim said in the research note. "Near-term upside may be limited, but we like the story for the long-term as HIMS remains committed to making healthcare accessible for all." GLP-1 medications treat diabetes and obesity and had been in shortage due to heavy demand. Although the analyst expects strong first-quarter results due to compounded demand for weight loss drugs, she believes the remainder of the year looks difficult. Hims & Hers will not be selling compounded versions of Wegovy and Ozempic after May 22, following the Food and Drug Administration's announcement that the GLP-1 shortage is over. Unless current GLP-1 users opt to switch to other oral medication options such as Liraglutide — in addition to the likelihood of users looking elsewhere for GLP-1 options — Him & Hers' current 2025 weight loss revenue guidance appears overly optimistic, according to Kim. In addition, "recession risk and muted consumer demand could be factors to monitor," Kim said. Year to date, shares of the telehealth company have advanced nearly 18%. The stock has soared about 127% over the last 12 months. —CNBC's Michael Bloom contributed to this report.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Omada Health IPO signals healthier market, avoids 'down-round' trend
Omada Health IPO signals healthier market, avoids 'down-round' trend

Yahoo

time2 hours ago

  • Yahoo

Omada Health IPO signals healthier market, avoids 'down-round' trend

The IPO market is starting to feel healthier. Omada Health, a 14-year-old company providing virtual care for chronic conditions like diabetes and hypertension between office visits, closed its first trading day on Friday at $23 a share, a 21% jump from the IPO price of $19. The IPO valued the company just above $1 billion (excluding employee options), a figure that's nearly identical to Omada's last private valuation of $1 billion set in its previous VC round. The debut is one of the first among recent IPOs that was not a so-called down-round. Many of the latest public listings, including Hinge, ServiceTitan, and Reddit, priced below their private market highs, though have faired well as public companies. For founder and CEO Sean Duffy, the successful public offering validates his decision to start a company that he believed the market desperately needed. In 2011, he dropped out of Harvard Medical School after realizing that chronic illness patients required more continuous support than the existing healthcare system delivered. Before the offering, he owned 4.1% of the company, according to Omada's offering document. Other significant shareholders included Revelation Partners (10.9%), US Venture Partners (9.9%), Andreessen Horowitz (9.6%), and FMR (9.3%). Duffy told TechCrunch that over his 14-year journey as a founder, he had many harrowing moments. "I didn't think our series A was going to come together because we were working on this commercial deal that didn't materialize, and that spooked one investor," he said. "As a young business, something tries to kill you every month," he continued. "And then as the business grows, it turns into like every quarter or six months, year, two years." One of the recent challenges for many digital health businesses is navigating the "collapse" of the market post-COVID boom. Omada steered through the turbulent times by seeking new, rising markets. It recently expanded its offerings to include diet management support for GLP-1 patients.

Trump orders FAA to remove supersonic flight restrictions: ‘Bold new chapter in aerospace innovation'
Trump orders FAA to remove supersonic flight restrictions: ‘Bold new chapter in aerospace innovation'

New York Post

time2 hours ago

  • New York Post

Trump orders FAA to remove supersonic flight restrictions: ‘Bold new chapter in aerospace innovation'

President Trump is boosting supersonic aviation in the United States. An executive order the commander in chief signed Friday directs the Federal Aviation Administration to repeal a 1973 rule prohibiting overland supersonic flight, establish new noise standards for aircraft and remove other regulations that get in the way of the development of high-speed planes. 'The United States stands at the threshold of a bold new chapter in aerospace innovation,' the president wrote in the order. Advertisement 'For more than 50 years, outdated and overly restrictive regulations have grounded the promise of supersonic flight over land, stifling American ingenuity, weakening our global competitiveness, and ceding leadership to foreign adversaries.' 3 'President Trump is Making Aviation Great Again,' the White House said of the his executive order. AFP via Getty Images Trump argued that advances in engineering and technology have now made supersonic air travel 'not just possible, but safe, sustainable, and commercially viable.' Advertisement 'This order begins a historic national effort to reestablish the United States as the undisputed leader in high-speed aviation,' the president declared. 'By updating obsolete standards and embracing the technologies of today and tomorrow, we will empower our engineers, entrepreneurs, and visionaries to deliver the next generation of air travel, which will be faster, quieter, safer, and more efficient than ever before.' Under current FAA rules, only military aircraft – flying in specially designated areas – are allowed to break the sound barrier over land. The 1973 ban on overland supersonic flight was primarily due to the disruptive impact of the sonic booms produced when aircraft exceed the speed of sound. 3 Boom Supersonic hopes to develop a commercially viable supersonic aircraft. AP Advertisement 3 The FAA banned supersonic flights over the United States in 1973, over noise concerns. Chad Robertson – However, new technology has enabled one aircraft maker, Boom Supersonic, to develop a plane that can cruise above Mach 1 without emitting a sonic boom. 'Supersonic is back, baby!' Boom Supersonic founder and CEO Blake Scholl wrote on X, noting that in January, his company's XB-1 aircraft became the first privately developed supersonic jet to break the sound barrier. 'And today…[Trump] broke the sound barrier…permanently!' he added. Advertisement Scholl argued that the ban on supersonic flight has 'crippled progress' in aviation for half a century, but with Trump's order in place, 'The supersonic race is on and a new era of commercial flight can begin.' 'By removing decades-old regulatory barriers and promoting cutting-edge supersonic technology, President Trump is Making Aviation Great Again,' the White House said in a statement.

TD Cowen Initiates Coverage of Target (TGT) With Hold Rating
TD Cowen Initiates Coverage of Target (TGT) With Hold Rating

Yahoo

time5 hours ago

  • Yahoo

TD Cowen Initiates Coverage of Target (TGT) With Hold Rating

On Wednesday, June 4, TD Cowen analysts began coverage of Target Corporation (NYSE:TGT), giving it a 'Hold' rating and setting a price target of $105. The analysts noted that the company's strong core business is supported by innovative and exclusive products. They also highlighted Target Corporation's (NYSE:TGT) digital fulfillment strategies, which are profitable and have potential for scaling. The analysts pointed out that the company has a 5-year revenue compound annual growth rate (CAGR) of 6.4%, higher than Walmart's 5.4%. A woman purchasing groceries at a Target store, with a cart full of products. Despite this, TD Cowen analysts noted some challenges that Target Corporation (NYSE:TGT) is facing in the near term. These include pressure from competitors on comparable sales and cost inefficiencies that are anticipated to continue throughout the year. The analysts mentioned tariffs and lower consumer confidence as factors contributing to the company's current challenges. They pointed out that these could affect Target Corporation's (NYSE:TGT) performance in the short term. While we acknowledge the potential of TGT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 11 Stocks That Will Bounce Back According To Analysts and 11 Best Stocks Under $15 to Buy According to Hedge Funds. Disclosure: None. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store